Robert T. deGavre
Director/Board Member at Cardeas Pharma Corp.
Profile
Robert T.
deGavre is currently a Director at Cardeas Pharma Corp.
Prior to this, he held Director positions at Corus Pharma, Inc. and Cardiac Insight, Inc. He also served as Treasurer at Inco Ltd.
and Treasurer & Vice President at Squibb Corp.
Additionally, he was an Officer in the United States Navy.
deGavre obtained his undergraduate degree from Princeton University.
Robert T. deGavre active positions
Companies | Position | Start |
---|---|---|
Cardeas Pharma Corp.
Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Director/Board Member | - |
Former positions of Robert T. deGavre
Companies | Position | End |
---|---|---|
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Director/Board Member | - |
United States Navy (District of Columbia) | Corporate Officer/Principal | - |
Cardiac Insight, Inc.
Cardiac Insight, Inc. Medical SpecialtiesHealth Technology Cardiac Insight, Inc. develops body worn sensing and computing technologies for applications in cardiology, respiratory, and other complex disease states. Its products inlcude Cardea SOLO and Cardea 20/20 ECG. The company was founded by Brad Harlow and David T. Linker in 2008 and is headquartered in Bellevue, WA. | Chairman | - |
Inco Ltd.
Inco Ltd. Other Metals/MineralsNon-Energy Minerals Vale Inco Ltd. manufactures nickel materials for manufacturing stainless steel and batteries. It also mines and processes copper, gold, cobalt and platinum metals. The company also manufactures flakes and powders for use in catalysts, electronics and paints. Its mining and processing operations are in Canada, Indonesia and the UK. Vale Inco was founded in 1901 and is located in Toronto, Canada. | Treasurer | - |
Squibb Corp. | Treasurer | - |
Training of Robert T. deGavre
Princeton University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Inco Ltd.
Inco Ltd. Other Metals/MineralsNon-Energy Minerals Vale Inco Ltd. manufactures nickel materials for manufacturing stainless steel and batteries. It also mines and processes copper, gold, cobalt and platinum metals. The company also manufactures flakes and powders for use in catalysts, electronics and paints. Its mining and processing operations are in Canada, Indonesia and the UK. Vale Inco was founded in 1901 and is located in Toronto, Canada. | Non-Energy Minerals |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Health Technology |
Cardeas Pharma Corp.
Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Health Technology |
Cardiac Insight, Inc.
Cardiac Insight, Inc. Medical SpecialtiesHealth Technology Cardiac Insight, Inc. develops body worn sensing and computing technologies for applications in cardiology, respiratory, and other complex disease states. Its products inlcude Cardea SOLO and Cardea 20/20 ECG. The company was founded by Brad Harlow and David T. Linker in 2008 and is headquartered in Bellevue, WA. | Health Technology |
Squibb Corp. | Health Technology |
United States Navy (District of Columbia) | Government |
- Stock Market
- Insiders
- Robert T. deGavre